The global medical devices industry is valued at approximately USD 581.1 billion in 2025 and is projected to grow at a CAGR of about 6.0% to reach approximately USD 825.5 billion by 2031 (forecast period 2025-2031, base year 2025). The report covers diagnostic and therapeutic device manufacturing and excludes pharmaceuticals and healthcare services.
The industry is segmented by type into In Vitro Diagnostics; Cardiovascular Devices; Diagnostic Imaging; Surgical and Minimally Invasive/Robotic Devices; Patient Monitoring and Diabetes Care; Orthopedic Devices; and Ophthalmic Devices, and by application into Hospitals; Diagnostic and Imaging Centers; Ambulatory Surgical Centers; Home Healthcare; and Clinics and Physician Offices. North America is the dominant region, Asia Pacific is the fastest-growing, and country forecasts cover 16 countries across five regions.
Population aging, rising chronic disease prevalence, and wider adoption of surgical robotics and connected diabetes care drive growth, while M&A is concentrated on surgical robotics and connected-care platforms. The report profiles 25 companies including Medtronic, Johnson & Johnson MedTech, Abbott Laboratories, Medline Industries, Siemens Healthineers, Stryker Corporation, Becton Dickinson, GE HealthCare, and includes Porter's Five Forces, PESTLE and SWOT analyses and a 2031 outlook for corporate strategy, investment, M&A and procurement teams.
The industry is segmented by type into In Vitro Diagnostics; Cardiovascular Devices; Diagnostic Imaging; Surgical and Minimally Invasive/Robotic Devices; Patient Monitoring and Diabetes Care; Orthopedic Devices; and Ophthalmic Devices, and by application into Hospitals; Diagnostic and Imaging Centers; Ambulatory Surgical Centers; Home Healthcare; and Clinics and Physician Offices. North America is the dominant region, Asia Pacific is the fastest-growing, and country forecasts cover 16 countries across five regions.
Population aging, rising chronic disease prevalence, and wider adoption of surgical robotics and connected diabetes care drive growth, while M&A is concentrated on surgical robotics and connected-care platforms. The report profiles 25 companies including Medtronic, Johnson & Johnson MedTech, Abbott Laboratories, Medline Industries, Siemens Healthineers, Stryker Corporation, Becton Dickinson, GE HealthCare, and includes Porter's Five Forces, PESTLE and SWOT analyses and a 2031 outlook for corporate strategy, investment, M&A and procurement teams.
Table of Contents
1. Executive Summary2. Industry Overview & Forecast
3. Market Segmentation by Type
4. Market Segmentation by Application
5. Regional Market Forecast
6. Country-Level Market Forecast
7. Growth Drivers & Inhibitors
8. Key Company Profiles (Medtronic, Johnson & Johnson MedTech, Abbott Laboratories, Medline Industries, Siemens Healthineers, Stryker Corporation, Becton Dickinson, GE HealthCare, Philips, Boston Scientific)
9. Competitive Landscape
10. Porter's Five Forces Analysis
11. PESTLE Analysis
12. SWOT Analysis
13. Future Trends & Outlook
Companies Mentioned
- Medtronic
- Johnson & Johnson MedTech
- Abbott Laboratories (Medical Devices)
- Medline Industries
- Siemens Healthineers
- Stryker Corporation
- Becton Dickinson (BD)
- GE HealthCare
- Philips (Health Systems)
- Boston Scientific
- Roche Diagnostics
- Baxter International
- Cardinal Health (Medical Segment)
- Danaher (Diagnostics/Life Sciences)
- Zimmer Biomet
- Intuitive Surgical
- Terumo Corporation
- Olympus Corporation
- Smith+Nephew
- Edwards Lifesciences
- Dexcom
- Hologic
- Insulet Corporation
- Alcon
- ResMed
